Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 17349943)

1.

The utility of PET brain imaging in the initial evaluation of dementia.

Weaver JD, Espinoza R, Weintraub NT.

J Am Med Dir Assoc. 2007 Mar;8(3):150-7. Epub 2006 Dec 22. Review.

PMID:
17349943
2.

Dopaminergic imaging: clinical utility now and in the future.

Walker Z, Rodda J.

Int Psychogeriatr. 2011 Sep;23 Suppl 2:S32-40. doi: 10.1017/S1041610211000883. Review.

PMID:
21843378
3.

A comparison of FDG-PET and blood flow SPECT in the diagnosis of neurodegenerative dementias: a systematic review.

Davison CM, O'Brien JT.

Int J Geriatr Psychiatry. 2014 Jun;29(6):551-61. doi: 10.1002/gps.4036. Epub 2013 Oct 9. Review.

PMID:
24123413
4.

Nuclear medicine imaging in dementia: a practical overview for hospitalists.

Toney LK, McCue TJ, Minoshima S, Lewis DH.

Hosp Pract (1995). 2011 Aug;39(3):149-60. doi: 10.3810/hp.2011.08.590. Review.

PMID:
21881402
5.

[Imaging diagnosis of dementia].

Ishii K.

Nihon Rinsho. 2014 Apr;72(4):681-6. Japanese.

PMID:
24796097
6.

Functional brain imaging: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(22):1-79. Epub 2006 Dec 1.

7.
8.

Imaging of the dopaminergic system in differential diagnosis of dementia.

Tatsch K.

Eur J Nucl Med Mol Imaging. 2008 Mar;35 Suppl 1:S51-7. doi: 10.1007/s00259-007-0702-0. Review.

PMID:
18214473
9.

Imaging biomarkers and their role in dementia clinical trials.

Chertkow H, Black S.

Can J Neurol Sci. 2007 Mar;34 Suppl 1:S77-83. Review.

PMID:
17469688
10.

[18 FDG PET imaging of the brain in the analysis of a dementia syndrome].

Golüke-Willemse GA, Csepán-Magyar R, Rijnders AJ.

Tijdschr Gerontol Geriatr. 2012 Oct;43(5):265-9. Dutch.

PMID:
23167069
11.

Fluorodeoxyglucose-positron emission tomography in the differential diagnosis of early-onset dementia: a prospective, community-based study.

Panegyres PK, Rogers JM, McCarthy M, Campbell A, Wu JS.

BMC Neurol. 2009 Aug 12;9:41. doi: 10.1186/1471-2377-9-41.

12.

Update on SPECT and PET in parkinsonism - part 1: imaging for differential diagnosis.

Meyer PT, Hellwig S.

Curr Opin Neurol. 2014 Aug;27(4):390-7. doi: 10.1097/WCO.0000000000000106. Review.

PMID:
24950013
13.

Accuracy of the clinical evaluation for frontotemporal dementia.

Mendez MF, Shapira JS, McMurtray A, Licht E, Miller BL.

Arch Neurol. 2007 Jun;64(6):830-5.

PMID:
17562930
14.

Single-photon emission computed tomography and positron emission tomography evaluations of patients with central motor disorders.

Seibyl JP.

Semin Nucl Med. 2008 Jul;38(4):274-86. doi: 10.1053/j.semnuclmed.2008.03.001. Review.

PMID:
18514083
15.

[Nuclear medicine imaging in neurodegenerative dementias].

Gratz S, Hahn U, Kaiser JW, Jarnig M, Schwarz J, Förstl H.

Dtsch Med Wochenschr. 2008 May;133 Suppl 1:S5-7. doi: 10.1055/s-2008-1075678. Review. German.

PMID:
18437639
16.

PET/CT in diagnosis of dementia.

Berti V, Pupi A, Mosconi L.

Ann N Y Acad Sci. 2011 Jun;1228:81-92. doi: 10.1111/j.1749-6632.2011.06015.x. Review.

17.

The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited.

Taylor DH Jr, Østbye T, Langa KM, Weir D, Plassman BL.

J Alzheimers Dis. 2009;17(4):807-15. doi: 10.3233/JAD-2009-1099.

18.

Neuroimaging for diagnosis of dementia.

Small GW, Leiter F.

J Clin Psychiatry. 1998;59 Suppl 11:4-7. Review.

PMID:
9731543
19.

[SPECT and PET in neurology].

Masdeu JC, Arbizu J, Toledo J, Valero M.

Neurologia. 2006 Jun;21(5):219-25. Review. Spanish.

PMID:
16788863
20.

Cost-effectiveness of 18F-fluorodeoxyglucose positron emission tomography in the assessment of early dementia from a Belgian and European perspective.

Moulin-Romsee G, Maes A, Silverman D, Mortelmans L, Van Laere K.

Eur J Neurol. 2005 Apr;12(4):254-63.

PMID:
15804241
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk